H. Freitas

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

Tony Mok, Yi‐Long Wu, Iveta Kudaba et al. · The Lancet · 2019 · 3.3K citations · Full text

Medicine, Oncology, Pharmacology +15

Tissue-Associated Bacterial Alterations in Rectal Carcinoma Patients Revealed by 16S rRNA Community Profiling

Andrew Maltez Thomas, Eliane C. Jesus, Ademar Lopes et al. · Frontiers in Cellular and Infection Microbiology · 2016 · 176 citations · Full text

Life Sciences, Microbiology, Oncology +17

Tumor Necrosis Factor-α and Interleukin-1β Mediate the Production of Nitric Oxide Involved in the Pathogenesis of Ifosfamide Induced Hemorrhagic Cystitis in Mice

Rita A. Ribeiro, H. Freitas, Míriam Cristina Alves de Oliveira Campos et al. · The Journal of Urology · 2002 · 93 citations

Veterinary Medicine, Pathobiology, Urology +15

Involvement of nitric oxide on the pathogenesis of irinotecan-induced intestinal mucositis: role of cytokines on inducible nitric oxide synthase activation

Roberto César Pereira Lima‐Júnior, Aline Almeida Figueiredo, H. Freitas et al. · Cancer Chemotherapy and Pharmacology · 2011 · 71 citations · Full text

Life Sciences, Pathobiology, Pathology +16

EGFR exon 20 insertion in lung adenocarcinomas among Hispanics (geno1.2-CLICaP)

Andrés F. Cardona, Leonardo Rojas, Zyanya Lucía Zatarain-Barrón et al. · Lung Cancer · 2018 · 60 citations

Medicine, Genetics, Molecular Genetics +12